Perspective Therapeutics, Inc. (CATX) › Gross ProfitPerspective Therapeutics, Inc. (CATX) — Gross ProfitAnnual figures by fiscal year, from SEC filings.2011: $1.16M2012: $703.2K2013: $150.2K2014: -$196.5K2015: $167.0K2016: $129.0K2017: $838.0K2018: $1.84M2019: $3.05M2020: $5.12M2021: $5.12M2022: $02023: $1.43M$1.43M2011Gross Profit (USD)2023Fiscal YearGross ProfitChange YoY2023$1.43M—2022$0-100.0%2021$5.12M-0.1%2020$5.12M+68.2%2019$3.05M+65.4%2018$1.84M+119.8%2017$838.0K+549.6%2016$129.0K-22.8%2015$167.0K+185.0%2014-$196.5K-230.8%2013$150.2K-78.6%2012$703.2K-39.2%2011$1.16M—Other metrics: RevenueCost of RevenueOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share